Genetics of drug-resistant Plasmodium falciparum malaria in the Venezuelan state of Bolivar

被引:37
作者
Contreras, CE
Cortese, JF
Caraballo, A
Plowe, CV
机构
[1] Univ Maryland, Ctr Vaccine Dev, Malaria Sect, Baltimore, MD 21201 USA
[2] Univ Cent, Sch Med, Inst Inmunol, Fac Med, Caracas 1050A, Venezuela
[3] Minist Hlth, Sch Publ Hlth, Malariol Dept, Caracas, Venezuela
关键词
D O I
10.4269/ajtmh.2002.67.400
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The state of Bolivar in Venezuela experiences episodic outbreaks of multidrug-resistant Plasmodium falciparum malaria. We obtained P. falciparum-infected blood samples in Bolivar in 1998-2000, and performed molecular assays for mutations conferring resistance to the antifolate combination of sulfadoxine-pyrimethamine (SP) and to chloroquine. All infections carried the dihydrofolate reductase (dhfr) S108A and N51I mutations, and 45% of the infections had the dhfr C50R mutation, which has been implicated in mid-level resistance to SP. Two dihydropteroate synthase (dhps) mutations also involved in SP resistance, A581G and K540E, were detected in 90% and 67% of the samples, respectively. The dhfr I164L mutation, which confers high-level resistance, was not identified. The P. falciparum chloroquine resistance transporter (pfcrt) K76T mutation, which is critical for chloroquine resistance, was found in 167 of 168 infections. Six dhfr/dhps allelotypes and four pfcrt-resistant alleles were observed. Their interrelationships suggest a semi-clonal propagation of P. falciparum malaria in Bolivar, and an invasion of multi-resistant pathogens from Brazil. Despite national restrictions on the use of SP and chloroquine, genotypic resistance to these therapies remains widespread in Bolivar.
引用
收藏
页码:400 / 405
页数:6
相关论文
共 32 条
[1]  
ALECRIM M, 1982, REV I MED TROP SA S6, V24, P52
[2]   Cycles of malaria associated with El Nino in Venezuela [J].
Bouma, MJ ;
Dye, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (21) :1772-1774
[3]   Malaria in the Americas: A model of reemergence [J].
Butler, WP ;
Roberts, DR .
MILITARY MEDICINE, 2000, 165 (12) :897-902
[4]   Chemotherapy of malaria and resistance to antimalarial drugs in Guayana area, Venezuela [J].
Caraballo, A ;
Rodriguez-Acosta, A .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 61 (01) :120-124
[5]   Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America [J].
Cortese, JF ;
Caraballo, A ;
Contreras, CE ;
Plowe, CV .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (07) :999-1006
[6]   Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast [J].
Cortese, JF ;
Plowe, CV .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1998, 94 (02) :205-214
[7]  
Djimdé A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403
[8]   Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria [J].
Djimdé, A ;
Doumbo, OK ;
Steketee, RW ;
Plowe, CV .
LANCET, 2001, 358 (9285) :890-891
[9]  
ESPINAL CA, 1985, AM J TROP MED HYG, V34, P675
[10]  
Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8